首页> 外文会议>Annual meeting exposition of the Controlled Release Society >Development and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administration.
【24h】

Development and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administration.

机译:Sn38新型脂质纳米胶囊制剂的研制与表征。

获取原文

摘要

A novel lipid nanocapsule formulation of 7-ethyl-10-hydroxy-camptothecin (Sn-38) was developed. Physicochemical properties and in vitro characterizations of nanoparticles are showing interest for oral administration.
机译:开发了新型的7-乙基-10-羟基喜树碱(Sn-38)脂质纳米胶囊制剂。纳米颗粒的理化性质和体外表征显示出对口服给药的兴趣。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号